Showing results (31-40 of 554) with videos related to
Sort By:
Pageof 56
American Journal of Clinical Oncology|May 29, 2019
Clinical Features of Rituximab-associated Gastrointestinal ToxicitiesNiharika Mallepally, Hamzah Abu-Sbeih, Osman Ahmed, et al.Expert Review of Vaccines|July 11, 2006
Therapeutic lymphoma vaccines: importance of T-cell immunitySattva S Neelapu, Seung-Tae Lee, Hong Qin, et al.Blood|June 1, 2012
Essential role of TAK1 in regulating mantle cell lymphoma survivalDaniela Buglio, Sangeetha Palakurthi, Kate Byth, et al.Blood|September 15, 2009
Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunityHong Qin, Soung-chul Cha, Sattva S Neelapu, et al.British Journal of Clinical Pharmacology|May 29, 2020
Chimeric antigen receptor T-cell therapy toxicitiesUri Greenbaum, Partow Kebriaei, Samer A Srour, et al.British Journal of Haematology|September 25, 2009
Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitorsAnnunziata Gloghini, Daniela Buglio, Noor M Khaskhely, et al.Plos One|August 13, 2013
Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphomaZheng Chen, Eric F Pittman, Jorge Romaguera, et al.Journal for Immunotherapy of Cancer|May 16, 2019
Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flareSang T Kim, Mohamad Bittar, Hyun J Kim, et al.Blood|June 12, 2004
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivoArya Biragyn, Pier Adelchi Ruffini, Marta Coscia, et al.Journal of Translational Medicine|March 31, 2004
A modified human ELISPOT assay to detect specific responses to primary tumor cell targetsAnatoli Malyguine, Susan L Strobl, Kimberly A Shafer-Weaver, et al.Pageof 56